arge scaled prospective cohor and analysis of clinical outcomes of patents with metastatic or recurrent breast cancer
Not Applicable
Recruiting
- Conditions
- Neoplasms
- Registration Number
- KCT0001221
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
• patients with metastatic or recurrent breast cancer at diagnosis
• patients who are expected to receive chemotherapy, hormone therapy and targeted therapy
• patients who had received or are being treated with adjuvant therapy
• more than or eqaul to 18 years old
• Patients who can understand and consent the study
Exclusion Criteria
• patients with mental retardation or severe psychological disease
• unfit patients, based on investigator's decision
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the construction of prospective cohort for patients with metastatic or recurrent breast cancer in Korea
- Secondary Outcome Measures
Name Time Method to analyze regimen, trend and clinical outcome of chemotherapy, hormone therapy and targeted therapy;to evaluate the quality of life;to compare the efficacy or cost-effectiveness between each treatment